USD 0.25
(-2.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 37.5 Thousand USD | 63459.32% |
2021 | 59.00 USD | -90.82% |
2020 | 643.00 USD | -86.95% |
2019 | 4927.00 USD | -89.26% |
2018 | 45.86 Thousand USD | -92.9% |
2017 | 645.65 Thousand USD | 166.79% |
2016 | 242 Thousand USD | 354.34% |
2015 | 53.26 Thousand USD | -67.26% |
2014 | 162.67 Thousand USD | 5216.24% |
2013 | 3060.00 USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | -100.0% |
2010 | 69.07 Thousand USD | 188.96% |
2009 | 23.9 Thousand USD | 191.86% |
2008 | 8190.00 USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | - USD | -100.0% |
2024 Q2 | - USD | 0.0% |
2023 FY | - USD | -100.0% |
2023 Q1 | - USD | -100.0% |
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | 6768.00 USD | 0.0% |
2022 Q4 | 37.50 USD | -99.9% |
2022 Q1 | - USD | 100.0% |
2022 Q2 | - USD | 0.0% |
2022 Q3 | 37.5 Thousand USD | 0.0% |
2022 FY | 37.5 Thousand USD | 63459.32% |
2021 Q1 | 59.00 USD | -26.25% |
2021 FY | 59.00 USD | -90.82% |
2021 Q4 | -59.00 USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | -100.0% |
2020 FY | 643.00 USD | -86.95% |
2020 Q4 | 80.00 USD | -41.18% |
2020 Q3 | 136.00 USD | 0.0% |
2020 Q2 | 136.00 USD | -53.26% |
2020 Q1 | 291.00 USD | 101.45% |
2019 FY | 4927.00 USD | -89.26% |
2019 Q1 | - USD | -100.0% |
2019 Q4 | -20.08 Thousand USD | 0.0% |
2019 Q3 | - USD | -100.0% |
2019 Q2 | 25 Thousand USD | 0.0% |
2018 FY | 45.86 Thousand USD | -92.9% |
2018 Q4 | 5036.00 USD | -44.34% |
2018 Q1 | 29.92 Thousand USD | -90.32% |
2018 Q2 | 1851.00 USD | -93.82% |
2018 Q3 | 9048.00 USD | 388.82% |
2017 Q4 | 309.1 Thousand USD | 357.28% |
2017 Q3 | 67.59 Thousand USD | 61.66% |
2017 Q2 | 41.81 Thousand USD | -81.59% |
2017 FY | 645.65 Thousand USD | 166.79% |
2017 Q1 | 227.12 Thousand USD | 43.32% |
2016 Q1 | 35.82 Thousand USD | 2688.17% |
2016 Q3 | 20.84 Thousand USD | -22.37% |
2016 Q4 | 158.48 Thousand USD | 660.29% |
2016 FY | 242 Thousand USD | 354.34% |
2016 Q2 | 26.85 Thousand USD | -25.05% |
2015 Q1 | 9892.00 USD | -37.8% |
2015 FY | 53.26 Thousand USD | -67.26% |
2015 Q4 | 1285.00 USD | -93.61% |
2015 Q3 | 20.12 Thousand USD | -8.39% |
2015 Q2 | 21.96 Thousand USD | 122.06% |
2014 Q2 | - USD | -100.0% |
2014 Q4 | 15.9 Thousand USD | 881.73% |
2014 Q3 | 1620.00 USD | 0.0% |
2014 FY | 162.67 Thousand USD | 5216.24% |
2014 Q1 | 146.77 Thousand USD | 4896.5% |
2013 Q2 | 1440.00 USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q4 | -3060.00 USD | -288.89% |
2013 Q3 | 1620.00 USD | 12.5% |
2013 FY | 3060.00 USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | -100.0% |
2011 Q1 | - USD | 100.0% |
2011 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2010 Q4 | -32.08 Thousand USD | -195.47% |
2010 Q3 | 33.61 Thousand USD | 0.0% |
2010 Q2 | - USD | -100.0% |
2010 Q1 | 35.46 Thousand USD | 48.35% |
2010 FY | 69.07 Thousand USD | 188.96% |
2009 Q1 | - USD | -100.0% |
2009 FY | 23.9 Thousand USD | 191.86% |
2009 Q4 | 23.9 Thousand USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 Q4 | 8190.00 USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | 8190.00 USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | 100.0% |
Ansell Limited | 1.61 Billion USD | 100.0% |
Ansell Limited | 1.61 Billion USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 184.64 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | 135.05 Thousand USD | 100.0% |
Psykey, Inc. | 419.29 Thousand USD | 100.0% |
ConvaTec Group Plc | 2.19 Billion USD | 100.0% |
ConvaTec Group Plc | 2.14 Billion USD | 100.0% |
Encision Inc. | 6.58 Million USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | - USD | NaN% |
Innovative MedTech Inc. | 1.82 Million USD | 100.0% |
LifePoint, Inc. | -18.5 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | 986.22 Thousand USD | 100.0% |
Reflect Scientific, Inc. | 1.08 Million USD | 100.0% |
SmileDirectClub, Inc. | 470.74 Million USD | 100.0% |
Sector 10, Inc. | - USD | NaN% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 100.0% |
SheerVision, Inc. | 3.49 Million USD | 100.0% |
Vasamed, Inc. | 1.38 Million USD | 100.0% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | 100.0% |
Yubo International Biotech Limited | 104.28 Thousand USD | 100.0% |